Coronavirus
India authorizes “world’s COVID-19 vaccine,” created in Texas
India has just become the first nation to authorize a cheap and easy to manufacture new COVID-19 vaccine called Corbevax.
How can Moderna and Pfizer adjust vaccines for omicron? A microbiologist answers 5 questions
If the omicron variant of the coronavirus is different enough from the original variant, existing vaccines might not be as effective.
Needle-free COVID-19 vaccine is in human trials
A needle-free COVID-19 vaccine now in human trials could protect us against both this disease and future coronavirus outbreaks.
This chewing gum traps the coronavirus
A new chewing gum may help reduce the spread of COVID-19 by neutralizing the virus before it can leave an infected person’s mouth.
Is Omicron the COVID variant we have been waiting for?
There is no rule that will force Omicron or another COVID variant to become less deadly over time, but there is reason for hope.
How the new coronavirus variant was found and what we know so far
Omicron is a new 'variant of concern' but there's still so much about it that we don't know.
Deal brings COVID-19 vaccines into conflict zones
The U.S. has brokered a deal between Johnson & Johnson and the COVAX initiative to get COVID-19 vaccines to people in conflict zones.
Pfizer’s antiviral pill cuts COVID-19 hospitalization, death by 89%
Pfizer’s antiviral pill to treat COVID-19 cut the risk of hospitalization or death by 89%, according to early results from a phase 2/3 trial.
Merck is making its COVID-19 antiviral pill more affordable to low-income countries
Drug maker Merck has agreed to license a promising antiviral pill to treat COVID-19 to low- and middle-income countries for free.
You can now mix and match COVID-19 booster shots
Americans eligible for COVID-19 booster shots no longer need to stick to one brand. Here’s why that’s a big deal.